Chlorproguanil
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Chlorproguanil
- DrugBank Accession Number
- DB12314
- Background
Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 288.18
Monoisotopic: 287.0704509 - Chemical Formula
- C11H15Cl2N5
- Synonyms
- Chlorproguanil
- Chlorproguanilum
- Clorproguanil
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcetophenazine The risk or severity of QTc prolongation can be increased when Chlorproguanil is combined with Acetophenazine. Alimemazine The risk or severity of QTc prolongation can be increased when Chlorproguanil is combined with Alimemazine. Ambroxol The risk or severity of methemoglobinemia can be increased when Chlorproguanil is combined with Ambroxol. Artemether The risk or severity of QTc prolongation can be increased when Chlorproguanil is combined with Artemether. Articaine The risk or severity of methemoglobinemia can be increased when Chlorproguanil is combined with Articaine. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Chlorproguanil hydrochloride 6T04V14CU9 6001-93-0 SVJMILFDDBKCGG-UHFFFAOYSA-N
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as dichlorobenzenes. These are compounds containing a benzene with exactly two chlorine atoms attached to it.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Halobenzenes
- Direct Parent
- Dichlorobenzenes
- Alternative Parents
- Biguanides / Aryl chlorides / Propargyl-type 1,3-dipolar organic compounds / Carboximidamides / Organopnictogen compounds / Organochlorides / Imines / Hydrocarbon derivatives
- Substituents
- 1,2-dichlorobenzene / Aromatic homomonocyclic compound / Aryl chloride / Aryl halide / Biguanide / Carboximidamide / Guanidine / Hydrocarbon derivative / Imine / Organic 1,3-dipolar compound
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8O3249M729
- CAS number
- 537-21-3
- InChI Key
- ISZNZKHCRKXXAU-UHFFFAOYSA-N
- InChI
- InChI=1S/C11H15Cl2N5/c1-6(2)16-10(14)18-11(15)17-7-3-4-8(12)9(13)5-7/h3-6H,1-2H3,(H5,14,15,16,17,18)
- IUPAC Name
- 1-[N'-(3,4-dichlorophenyl)carbamimidamido]-N-(propan-2-yl)methanimidamide
- SMILES
- CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 9571037
- PubChem Substance
- 347828579
- ChemSpider
- 20950
- ChEBI
- 135192
- ChEMBL
- CHEMBL1213553
- ZINC
- ZINC000000001136
- PharmGKB
- PA165857067
- Wikipedia
- Chlorproguanil
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Malaria caused by Plasmodium falciparum 2 3 Completed Not Available Malaria / Malaria caused by plasmodium vivax 1 3 Completed Treatment Fever / Malaria 1 3 Completed Treatment Malaria 2 3 Completed Treatment Malaria caused by Plasmodium falciparum 2
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0808 mg/mL ALOGPS logP 2.88 ALOGPS logP 2.99 Chemaxon logS -3.6 ALOGPS pKa (Strongest Basic) 10 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 5 Chemaxon Polar Surface Area 83.79 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 96.46 m3·mol-1 Chemaxon Polarizability 28.87 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-01ox-9780000000-ee57aa36f1029f4c45cd Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-0090000000-4624cc6537b5be5dafde Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0059-1590000000-95f5217afde18f5adc07 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-01p9-8390000000-bdb8d1575272ed4eaa8c Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00lu-7900000000-b1ef9b96c64522a65eb9 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-01p6-9300000000-e9ce725e4050fbc11cff Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0159-9300000000-c260f4c941b87cb9f870 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 171.38725 predictedDeepCCS 1.0 (2019) [M+H]+ 173.74525 predictedDeepCCS 1.0 (2019) [M+Na]+ 179.8384 predictedDeepCCS 1.0 (2019)
Drug created at October 20, 2016 21:55 / Updated at February 21, 2021 18:53